SCHEMBL23735795

SCHEMBL23735795

CCc1cc(OC)cc2cnn(C)c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
HTT P42858 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ELANE P08246 1/20 0.36
MTOR P42345 1/20 0.36
HTR3A P46098 1/20 0.36
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
RAD52 P43351 1/20 0.35
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
NPBWR1 P48145 4/20 0.34
MCHR1 Q99705 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23341423 0.78 MEN1 (0.38) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL23735733 0.77 TUBB4A (0.35) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL19790258 0.77 ELANE (0.35) GLAHPGDHTTELANEMAPK1
SCHEMBL25696303 0.74 CA1 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL20315039 0.74 CRHR1 (0.39) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL24992571 0.74 MAPK1 (0.39) KDM4EHPGDHTTPRMT5WDR77
SCHEMBL27137437 0.74 MAPK1 (0.42) KDM4EALDH1A1HTTMAPK1CYP19A1
SCHEMBL20757767 0.69 TRPC5 (0.42) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL29702376 0.68 KAT2B (0.43) KDM4EALDH1A1HPGD
SCHEMBL10477357 0.67 ALDH1A1 (0.46) KDM4EALDH1A1HSD17B10ELANEKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed